In fact, although deleterious when generated in excess, NETs play an important role in the entrapment, neutralization and eradication of bacterial and fungal pathogens [43,44] and consequently the use of PAD4 inhibitors could increase the susceptibility of severe COVID-19 patients to secondary infections. This evidence concerns the gene PADI4 and infection.